JP2024517843A5 - - Google Patents
Info
- Publication number
- JP2024517843A5 JP2024517843A5 JP2023568104A JP2023568104A JP2024517843A5 JP 2024517843 A5 JP2024517843 A5 JP 2024517843A5 JP 2023568104 A JP2023568104 A JP 2023568104A JP 2023568104 A JP2023568104 A JP 2023568104A JP 2024517843 A5 JP2024517843 A5 JP 2024517843A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- vector
- vector system
- polynucleotide
- signal sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184737P | 2021-05-05 | 2021-05-05 | |
| US63/184,737 | 2021-05-05 | ||
| PCT/US2022/027870 WO2022235933A2 (en) | 2021-05-05 | 2022-05-05 | Compositions and methods for treating sensorineural hearing loss using stereocilin dual vector systems |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517843A JP2024517843A (ja) | 2024-04-23 |
| JP2024517843A5 true JP2024517843A5 (enExample) | 2025-05-08 |
Family
ID=83932494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568104A Pending JP2024517843A (ja) | 2021-05-05 | 2022-05-05 | ステレオシリン二重ベクター系を使用して感音性難聴を治療するための組成物及び方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240216540A1 (enExample) |
| EP (1) | EP4333905A4 (enExample) |
| JP (1) | JP2024517843A (enExample) |
| KR (1) | KR20240021166A (enExample) |
| CN (1) | CN117750983A (enExample) |
| AU (1) | AU2022271265A1 (enExample) |
| BR (1) | BR112023022833A2 (enExample) |
| CA (1) | CA3219054A1 (enExample) |
| CL (1) | CL2023003260A1 (enExample) |
| CO (1) | CO2023016804A2 (enExample) |
| IL (1) | IL308142A (enExample) |
| MX (1) | MX2023013053A (enExample) |
| WO (1) | WO2022235933A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021530227A (ja) | 2018-07-13 | 2021-11-11 | アコーオス インコーポレイテッド | 非症候性感音性聴力喪失の治療方法 |
| US20220054640A1 (en) * | 2018-12-11 | 2022-02-24 | Decibel Therapeutics, Inc. | Compositions and methods for the delivery of therapeutic agents across the round window membrane |
| WO2023064388A2 (en) * | 2021-10-12 | 2023-04-20 | Decibel Therapeutics, Inc. | Stereocilin promoters and uses thereof |
| CN116925239B (zh) * | 2023-07-17 | 2024-10-18 | 苏州星奥拓维生物技术有限公司 | 双载体系统表达Otof基因的组合物和方法 |
| US20260027327A1 (en) | 2024-07-26 | 2026-01-29 | Regeneron Pharmaceuticals, Inc. | Otic drug delivery system and methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2097538A4 (en) * | 2006-12-07 | 2011-11-30 | Switchgear Genomics | TRANSCRIPTION REAGULATION ELEMENTS OF BIOLOGICAL PATHS, TOOLS AND METHODS |
| CA2979120A1 (en) * | 2015-03-03 | 2016-09-09 | Fondazione Telethon | Multiple aav vector system for expressing genes over 5 kilobases, comprising at least one degradation signal and uses thereof |
| JP2021530227A (ja) * | 2018-07-13 | 2021-11-11 | アコーオス インコーポレイテッド | 非症候性感音性聴力喪失の治療方法 |
| US12534739B2 (en) * | 2018-10-11 | 2026-01-27 | Decibel Therapeutics, Inc. | AAV1 vectors and uses thereof for treatment of otic indications |
| EP3880827A4 (en) * | 2018-11-07 | 2023-04-26 | Akouos, Inc. | COMPOSITIONS AND METHODS FOR INDUCING DIFFERENTIATION OF A HAIR CELL |
| EP3921032A4 (en) * | 2019-02-08 | 2022-11-30 | Decibel Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS |
-
2022
- 2022-05-05 CA CA3219054A patent/CA3219054A1/en active Pending
- 2022-05-05 WO PCT/US2022/027870 patent/WO2022235933A2/en not_active Ceased
- 2022-05-05 JP JP2023568104A patent/JP2024517843A/ja active Pending
- 2022-05-05 IL IL308142A patent/IL308142A/en unknown
- 2022-05-05 US US18/289,028 patent/US20240216540A1/en active Pending
- 2022-05-05 EP EP22799595.8A patent/EP4333905A4/en active Pending
- 2022-05-05 KR KR1020237041742A patent/KR20240021166A/ko active Pending
- 2022-05-05 CN CN202280047724.4A patent/CN117750983A/zh active Pending
- 2022-05-05 BR BR112023022833A patent/BR112023022833A2/pt not_active Application Discontinuation
- 2022-05-05 MX MX2023013053A patent/MX2023013053A/es unknown
- 2022-05-05 AU AU2022271265A patent/AU2022271265A1/en not_active Abandoned
-
2023
- 2023-11-02 CL CL2023003260A patent/CL2023003260A1/es unknown
- 2023-12-04 CO CONC2023/0016804A patent/CO2023016804A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022190081A5 (enExample) | ||
| JP2024009857A5 (enExample) | ||
| JP2020511127A5 (enExample) | ||
| JP2022508182A5 (enExample) | ||
| JP2022549140A5 (enExample) | ||
| JP2022523679A5 (enExample) | ||
| JP2021512649A5 (enExample) | ||
| JP2022549380A5 (enExample) | ||
| RU2018116076A (ru) | Модифицированные гены атаксии фридрейха и векторы для генной терапии | |
| JP2022529631A5 (enExample) | ||
| JP2020519284A5 (enExample) | ||
| JP2022520803A5 (enExample) | ||
| JP2021514659A5 (enExample) | ||
| JP2023551873A5 (enExample) | ||
| JP2022551744A5 (enExample) | ||
| JP2023537358A5 (enExample) | ||
| JP2023535620A5 (enExample) | ||
| AU2019250249A1 (en) | Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases | |
| JP2022525302A5 (enExample) | ||
| JP2024512483A5 (enExample) | ||
| JP2023524024A5 (enExample) | ||
| JP2021520811A5 (enExample) | ||
| JP2023541443A5 (enExample) | ||
| JP2023520763A5 (enExample) | ||
| CN118460614A (zh) | 一种腺相关病毒Cap蛋白的表达框 |